Tweet
<img alt="" height="1" width="1" />
AstraZeneca, Novartis Drug Failures Prompt Sales, Profit Alerts
BusinessWeek
By Makiko Kitamura and Simeon Bennett Dec. 20 (Bloomberg) -- AstraZeneca Plc and Novartis AG said drugs in late-stage development for depression and hypertension failed in studies, prompting warnings about earnings and sales forecasts. ...
Sanofi, Novartis, Astrazeneca get poor results from trial tests on key drugsWashington Post
European Pharma Hit By Drug SetbacksWall Street Journal
AstraZeneca Joins Novartis in Reducing Sales Forecasts as Drugs Fail TestsBloomberg
San Francisco Chronicle -Salon -Boston Business Journal
all 111 news articles »
More...